Bank Hapoalim BM’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-14,450
| Closed | -$281K | – | 248 |
|
|
2021
Q1 | $281K | Sell |
14,450
-15,570
| -52% | -$303K | 0.04% | 202 |
|
|
2020
Q4 | $541K | Buy |
+30,020
| New | +$541K | 0.07% | 141 |
|
|
2020
Q3 | – | Sell |
-14,831
| Closed | -$387K | – | 196 |
|
|
2020
Q2 | $387K | Buy |
14,831
+350
| +2% | +$9.13K | 0.09% | 131 |
|
|
2020
Q1 | $258K | Sell |
14,481
-2,574
| -15% | -$45.9K | 0.08% | 143 |
|
|
2019
Q4 | $569K | Sell |
17,055
-10,175
| -37% | -$339K | 0.12% | 103 |
|
|
2019
Q3 | $653K | Buy |
27,230
+1,260
| +5% | +$30.2K | 0.16% | 87 |
|
|
2019
Q2 | $933K | Buy |
25,970
+1,845
| +8% | +$66.3K | 0.23% | 73 |
|
|
2019
Q1 | $891K | Buy |
+24,125
| New | +$891K | 0.21% | 76 |
|
|
2018
Q4 | – | Sell |
-4,670
| Closed | -$221K | – | 194 |
|
|
2018
Q3 | $221K | Sell |
4,670
-62,455
| -93% | -$2.96M | 0.05% | 169 |
|
|
2018
Q2 | $3.34M | Buy |
67,125
+14,825
| +28% | +$738K | 0.91% | 32 |
|
|
2018
Q1 | $2.6M | Buy |
+52,300
| New | +$2.6M | 0.67% | 37 |
|